| 臺大學術典藏 |
2020-04-28T07:25:34Z |
Complete response of urothelial carcinoma to chemotherapy in renal allograft recipients: A two-case study
|
Lin C.-C.;Chih-Hung Hsu;Pu Y.-S.; Lin C.-C.; CHIH-HUNG HSU; Pu Y.-S. |
| 臺大學術典藏 |
2020-04-28T07:25:34Z |
Weekly cisplatin plus infusional high-dose 5-fluorouracil and leucovorin (P-HDFL) for metastatic urothelial carcinoma: An effective regimen with low toxicity
|
Lin C.-C.;Chih-Hung Hsu;Huang C.-Y.;Cheng A.-L.;Chen J.;Vogelzang N.J.;Pu Y.-S.; Lin C.-C.; CHIH-HUNG HSU; Huang C.-Y.; Cheng A.-L.; Chen J.; Vogelzang N.J.; Pu Y.-S. |
| 臺大學術典藏 |
2020-04-28T07:25:32Z |
Prognostic Factors for Metastatic Urothelial Carcinoma Treated with Cisplatin and 5-Fluorouracil-Based Regimens
|
Pu Y.-S.;Cheng A.-L.;Huang K.-H.;Tsai Y.-C.;Huang C.-Y.;CHIH-HUNG HSU;Lin C.-C.; Lin C.-C.; CHIH-HUNG HSU; Huang C.-Y.; Tsai Y.-C.; Huang K.-H.; Cheng A.-L.; Pu Y.-S. |
| 臺大學術典藏 |
2020-04-28T07:25:28Z |
Induction Cisplatin and Fluorouracil-Based Chemotherapy Followed by Concurrent Chemoradiation for Muscle-Invasive Bladder Cancer
|
Cheng J.C.; Huang C.-Y.; Tsai Y.-C.; Hsu F.-M.; Huang K.-H.; Cheng A.-L.; Pu Y.-S.; CHIH-HUNG HSU; Lin C.-C.;Chih-Hung Hsu;Cheng J.C.;Huang C.-Y.;Tsai Y.-C.;Hsu F.-M.;Huang K.-H.;Cheng A.-L.;Pu Y.-S.; Lin C.-C. |
| 臺大學術典藏 |
2020-04-28T07:25:14Z |
A role of multimodality bladder-preserving therapy in patients with muscle-invasive bladder cancer plus hydronephrosis with or without pelvic nodal involvement
|
Tsai Y.-C.; Chiang Y.;Cheng J.C.-H.;Huang C.-Y.;Tsai Y.-C.;Lin C.-C.;Chih-Hung Hsu;Cheng A.-L.;Pu Y.-S.; Chiang Y.; Cheng J.C.-H.; Huang C.-Y.; Lin C.-C.; CHIH-HUNG HSU; Cheng A.-L.; Pu Y.-S. |
| 臺大學術典藏 |
2020-04-27T08:45:14Z |
Synergistic blockade of EGFR and HER2 by new-generation EGFR tyrosine kinase inhibitor enhances radiation effect in bladder cancer cells
|
Tsai Y.-C.;Ho P.-Y.;Tzen K.-Y.;Tuan T.-F.;Liu W.-L.;Cheng A.-L.;Pu Y.-S.;Chia-Hsien Cheng; Tsai Y.-C.; Ho P.-Y.; Tzen K.-Y.; Tuan T.-F.; Liu W.-L.; Cheng A.-L.; Pu Y.-S.; CHIA-HSIEN CHENG |
| 臺大學術典藏 |
2020-04-27T08:45:09Z |
Comparative analysis between radical cystectomy and trimodality therapy for clinical Stage II Bladder Cancer: Experience from a tertiary referral center
|
Hong J.-H.;Lin Y.-H.;Lu Y.-C.;Chiang Y.;Tai H.-C.;Huang K.-H.;Chia-Hsien Cheng;Pu Y.-S.; Huang K.-H.; CHIA-HSIEN CHENG; Pu Y.-S.; Tai H.-C.; Hong J.-H.; Lin Y.-H.; Lu Y.-C.; Chiang Y. |
| 臺大學術典藏 |
2020-04-27T08:45:09Z |
A role of multimodality bladder-preserving therapy in patients with muscle-invasive bladder cancer plus hydronephrosis with or without pelvic nodal involvement
|
Chiang Y.;Chia-Hsien Cheng;Huang C.-Y.;Tsai Y.-C.;Lin C.-C.;Hsu C.-H.;Cheng A.-L.;Pu Y.-S.; Chiang Y.; CHIA-HSIEN CHENG; Huang C.-Y.; Tsai Y.-C.; Lin C.-C.; Hsu C.-H.; Cheng A.-L.; Pu Y.-S. |
| 臺大學術典藏 |
2020-03-27T05:28:59Z |
Emphysematous pyelonephritis: Clinical characteristics and prognostic factors
|
Pong Y.-H.; Chen C.-H.; Pu Y.-S.; PO-REN HSUEH; Huang C.-Y.; Chiang B.-J.; Lu Y.-C.; Huang C.-Y.;PO-REN HSUEH;Pu Y.-S.;Chen C.-H.;Pong Y.-H.;Chiang B.-J.;Lu Y.-C. |
| 臺大學術典藏 |
2020-03-27T05:28:58Z |
Predictors of failure of conservative treatment among patients with emphysematous pyelonephritis
|
Chiang B.-J.; Pong Y.-H.; Huang K.-H.; PO-REN HSUEH; Huang C.-Y.; Pu Y.-S.; Lu Y.-C.; Pu Y.-S.;Huang C.-Y.;PO-REN HSUEH;Huang K.-H.;Pong Y.-H.;Chiang B.-J.;Lu Y.-C. |
| 臺大學術典藏 |
2020-03-27T05:28:48Z |
Recommended initial antimicrobial therapy for emphysematous pyelonephritis
|
Pu Y.-S.;Huang C.-Y.;PO-REN HSUEH;Pong Y.-H.;Chiang B.-J.;Hong J.-H.;Lu Y.-C.; Lu Y.-C.; Hong J.-H.; Chiang B.-J.; Pong Y.-H.; PO-REN HSUEH; Huang C.-Y.; Pu Y.-S. |
| 臺大學術典藏 |
2020-03-27T02:03:27Z |
Metallic ureteral stents in malignant ureteral obstruction: Short-term results and radiological features predicting stent failure in patients with non-urological malignancies
|
KAO-LANG LIU; Pu Y.-S.; Yu H.-J.; Wang S.-M.; Hsu J.-S.; Chow P.-M.;Hsu J.-S.;Wang S.-M.;Yu H.-J.;Pu Y.-S.;Kao-Lang Liu; Chow P.-M. |
| 臺大學術典藏 |
2020-03-27T02:03:23Z |
Long-term outcomes of nephrectomy and inferior vena cava thrombectomy in patients with advanced renal cell carcinoma: A single-center experience
|
Pu Y.-S.; Wang S.-M.; Huang K.-H.; Tai H.-C.; Huang C.-Y.; Chow P.-M.; Lin W.-C.; KAO-LANG LIU; Lien C.-C.; Lien C.-C.;Kao-Lang Liu;Chow P.-M.;Lin W.-C.;Tai H.-C.;Huang C.-Y.;Wang S.-M.;Huang K.-H.;Pu Y.-S. |
| 臺大學術典藏 |
2020-03-27T02:03:21Z |
Long-term outcomes of nephrectomy and inferior vena cava thrombectomy in patients with advanced renal cell carcinoma: A single-center experience
|
Lin W.-C.; Tai H.-C.; Huang C.-Y.; Wang S.-M.; Huang K.-H.; Pu Y.-S.; Chou P.-M.; KAO-LANG LIU; Lien C.-C.; Lien C.-C.;Kao-Lang Liu;Chou P.-M.;Lin W.-C.;Tai H.-C.;Huang C.-Y.;Wang S.-M.;Huang K.-H.;Pu Y.-S. |
| 臺大學術典藏 |
2020-03-23T05:54:16Z |
RBMY, a male germ cell-specific RNA-binding protein, activated in human liver cancers and transforms rodent fibroblasts
|
Chang M.-H.; Ni Y.-H.; Chang C.-J.; Chou W.-C.; Lee Y.-C.; CHIUNG-NIEN CHEN; Pu Y.-S.; Jeng Y.-M.; Lee P.-H.; Hsu H.-C.; Tsuei D.-J.; Tsuei D.-J.;Hsu H.-C.;Lee P.-H.;Jeng Y.-M.;Pu Y.-S.;Chiung-Nien Chen;Lee Y.-C.;Chou W.-C.;Chang C.-J.;Ni Y.-H.;Chang M.-H. |
| 臺大學術典藏 |
2020-03-06T08:25:37Z |
RBMY, a male germ cell-specific RNA-binding protein, activated in human liver cancers and transforms rodent fibroblasts
|
Tsuei D.-J.;Hsu H.-C.;Lee P.-H.;Yung-Ming Jeng;Pu Y.-S.;Chen C.-N.;Lee Y.-C.;Chou W.-C.;Chang C.-J.;Ni Y.-H.;Chang M.-H.; Tsuei D.-J.; Hsu H.-C.; Lee P.-H.; YUNG-MING JENG; Pu Y.-S.; Chen C.-N.; Lee Y.-C.; Chou W.-C.; Chang C.-J.; Ni Y.-H.; Chang M.-H. |
| 臺大學術典藏 |
2020-03-06T08:25:03Z |
MLN4924, a Novel NEDD8-activating enzyme inhibitor, exhibits antitumor activity and enhances cisplatin-induced cytotoxicity in human cervical carcinoma: In vitro and in vivo study
|
Liao S.-M.; Chou C.-T.; Chiang C.-K.; Chiu W.-S.; Chiu T.-Y.; Pu Y.-S.; Ho I.-L.; Wang Z.-H.; Chang S.-C.; Liu S.-H.; YUNG-MING JENG; Huang K.-H.; Lin W.-C.;Kuo K.-L.;Shi C.-S.;Wu J.-T.;Hsieh J.-T.;Chang H.-C.;Liao S.-M.;Chou C.-T.;Chiang C.-K.;Chiu W.-S.;Chiu T.-Y.;Pu Y.-S.;Ho I.-L.;Wang Z.-H.;Chang S.-C.;Liu S.-H.;Yung-Ming Jeng;Huang K.-H.; Lin W.-C.; Kuo K.-L.; Shi C.-S.; Wu J.-T.; Hsieh J.-T.; Chang H.-C. |
| 臺大學術典藏 |
2020-03-03T03:06:45Z |
Diffusion MRI predicts transrectal ultrasound biopsy results in prostate cancer detection
|
Chen Y.-J. ;Pu Y.-S. ;Chueh S.-C. ;Shun C.-T. ;Chu W.-C. ;Wen-Yih Tseng; Chen Y.-J.; Pu Y.-S.; Chueh S.-C.; Shun C.-T.; Chu W.-C.; WEN-YIH TSENG |
| 臺大學術典藏 |
2020-03-03T03:06:39Z |
Washout gradient in dynamic contrast-enhanced MRI is associated with tumor aggressiveness of prostate cancer
|
Chen Y.-J.; Chu W.-C.; Pu Y.-S.; Chueh S.-C.; Shun C.-T.; WEN-YIH TSENG |
| 臺大學術典藏 |
2020-02-26T01:33:45Z |
Prediabetes Is Associated with an Increased Risk of Testosterone Deficiency, Independent of Obesity and Metabolic Syndrome
|
Ho, C.-H.; Yu, H.-J.; Wang, C.-Y.; Jaw, F.-S.; Hsieh, J.-T.; Liao, W.-C.; Pu, Y.-S.; Liu, S.-P.; FU-SHAN JAW |
| 臺大學術典藏 |
2020-02-14T06:07:48Z |
Comparative analysis between radical cystectomy and trimodality therapy for clinical Stage II Bladder Cancer: Experience from a tertiary referral center
|
JIAN-HUA HONG; Lin Y.-H.; Lu Y.-C.; Chiang Y.; Tai H.-C.; Huang K.-H.; Cheng C.-H.; Pu Y.-S. |
| 臺大學術典藏 |
2020-02-14T06:07:48Z |
Advantage of early orchiopexy for undescended testis: Analysis of testicular growth percentage ratio in patients with unilateral undescended testicle
|
Tseng C.-S.; Chiang I.-N.; Hong C.-H.; Lu Y.-C.; JIAN-HUA HONG; Chang H.-C.; Huang K.-H.; Pu Y.-S. |
| 臺大學術典藏 |
2020-02-14T06:07:48Z |
Comparative analysis between radical cystectomy and trimodality therapy for clinical stage II bladder cancer - Experience from a tertiary referral center
|
JIAN-HUA HONG; Lin Y.-H.; Lu Y.-C.; Chiang Y.; Tai H.-C.; Huang K.-H.; Cheng C.-H.; Pu Y.-S. |
| 臺大學術典藏 |
2020-02-14T06:07:48Z |
Recommended initial antimicrobial therapy for emphysematous pyelonephritis
|
Pu Y.-S.;Huang C.-Y.;Hsueh P.-R.;Pong Y.-H.;Chiang B.-J.;JIAN-HUA HONG;Lu Y.-C.; Lu Y.-C.; JIAN-HUA HONG; Chiang B.-J.; Pong Y.-H.; Hsueh P.-R.; Huang C.-Y.; Pu Y.-S. |
| 臺大學術典藏 |
2020-02-14T06:07:47Z |
Preoperative %p2PSA and Prostate Health Index Predict Pathological Outcomes in Patients with Prostate Cancer Undergoing Radical Prostatectomy
|
Chang H.-C.; Huang K.-H.; Lee Y.-J.; Chow P.-M.; Chiang I.-N.; Hung S.-C.; Chiang C.-H.; Chang Y.-K.; Liu S.-P.; Lu Y.-C.; Pu Y.-S.; JIAN-HUA HONG; Cheng Y.-T.; Huang C.-Y.; Chen C.-H.; Chiu S.-T. |
